Alumis (ALMS) Other financing activities (2023 - 2025)
Alumis' (ALMS) quarterly Other financing activities came in at $829000.0 in Q4 2025, down 99.46% year-on-year from $153.3 million in Q4 2024, and down 99.46% on a QoQ basis from $153.3 million in Q4 2024.
Alumis (ALMS) Other financing activities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Other financing activities data on file, last reported at $829000.0 in Q4 2025.
- On a quarterly basis, Other financing activities fell 99.46% year-over-year to $829000.0 in Q4 2025; TTM through Dec 2025 was $193.6 million, a 0.15% change from a year earlier, with the FY2025 full-year figure at $1.6 million, down 99.17% from the prior year.
- Other financing activities for Q4 2025 stood at $829000.0, down from $153.3 million in the prior quarter.
- Over the last five years, Other financing activities for ALMS reached as high as $153.3 million in Q4 2024 and fell as low as -$210000.0 in Q3 2023.
- Historically, Other financing activities has averaged $27.8 million across 3 years, with a median of $508000.0 in 2024.
- Across the five-year window, Other financing activities jumped 33013.61% in 2024 and tumbled 99.46% in 2025, its largest moves.
- Year by year, Other financing activities stood at $463000.0 in 2023, then soared by 33013.61% to $153.3 million in 2024, then tumbled by 99.46% to $829000.0 in 2025.
- Per Business Quant data, the three most recent Other financing activities figures were $829000.0 in Q4 2025, $153.3 million in Q4 2024, and $39.5 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Alumis | 2.32 Bn | 2.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 829,000.00 |
| Dec 31, 2025 | 829,000.00 |
| Dec 31, 2024 | 153.32 Mn |
| Dec 31, 2024 | 153.32 Mn |
| Sep 30, 2024 | 39.46 Mn |
| Sep 30, 2024 | 39.46 Mn |
| Jun 30, 2024 | 508,000.00 |
| Jun 30, 2024 | 508,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 463,000.00 |
| Dec 31, 2023 | 463,000.00 |
| Sep 30, 2023 | -210,000.00 |
| Sep 30, 2023 | -210,000.00 |